Skip to main content
. 2022 Oct 17;13:1016472. doi: 10.3389/fimmu.2022.1016472

Figure 1.

Figure 1

Workflow of enrolled patients. Twenty-eight subjects were recruited for this study; 13 were diagnosed with latent tuberculosis (LTB), and 15 with active drug-sensitive tuberculosis (DS-TB). TST, Tuberculin skin test; PCR Xpert MTB/RIF, Polymerase Chain Reaction Xpert Mycobacterium Tuberculosis/Rifampicin; R, resistant.